ETF profile for iShares Health Innovation Active ETF (BMED) from the issuer: top holdings, net assets, expense ratio and shares outstanding.
BMED ETF Profile
| Family: |
Blackrock (iShares) |
| Name: |
iShares Health Innovation Active ETF |
|
|
| Inception Date: |
29-Sep-2020 |
| Termination Date: |
|
| Investment Objective: |
iShares Health Innovation Active ETF will invest at least 80% of its net assets plus any borrowings for investment purposes in equity securities of companies principally engaged in the health sciences group of industries. Companies in the health sciences group of industries include health care providers as well as businesses involved in researching, developing, producing, distributing or delivering medical, dental, optical, pharmaceutical or biotechnology products, supplies, equipment or services or that provide support services to these companies. These companies also include those that own or operate health facilities and hospitals or provide related administrative, management or financial support. Other companies in the health sciences group of industries in which the Fund may invest include clinical testing laboratories diagnostics hospital, laboratory or physician ancillary products and support services rehabilitation services employer health insurance management services and vendors of goods and services specifically to companies engaged in the health sciences. The Fund will concentrate its investments in the health sciences group of industries. |
|
|
| Prospectus |
|
|
|
| Top 10 Holdings |
|
|
| GILEAD SCIENCES |
GILD |
5.9451% |
| BLK CSH FND TREASURY SL AGENCY |
XTSLA |
5.3399% |
| MODERNA |
MRNA |
5.3233% |
| DANAHER |
DHR |
5.1096% |
| ABBVIE |
ABBV |
4.8695% |
| THERMO FISHER SCIENTIFIC |
TMO |
4.2702% |
| BIOGEN |
BIIB |
3.7128% |
| METTLER TOLEDO |
MTD |
3.5380% |
| IQVIA HOLDINGS INC |
IQV |
3.4465% |
| VERTEX PHARMACEUTICALS |
VRTX |
3.3911% |
|
Top 10 Holdings Weight: |
44.9% |
| Number of Holdings: |
62 |
| Shares Outstanding: |
400,000 |
| Total Net Assets: |
14,441,080 |
| NAV: |
36.07 |
| Net Expense Ratio: |
0.55% |
|
|
| Asset Class: |
Equities (Stocks) |
| Developed or Emerging: |
Funds Combining Developed & Emerging Exposure |
| Country: |
|
| Region: |
|
| Strategy: |
|
| Currency: |
|
| Commodity: |
|
| Sector: |
Healthcare |
| Industry: |
|
| Dividend Type: |
|
| Tax Exempt State: |
|
| Maturity Duration: |
|
| Market Cap: |
Broad Market / Multi-Cap |
| Credit Quality: |
|
| Mortgage Bond Types: |
|
| Bond Type: |
|
| Gov't Bond Types: |
|
| Reit Type: |
|
| Leverage Direction/Factor: |
|
| Is Currency Hedged: |
No |
| US or Ex-US: |
Global |
